![Surviving-an-FDA-GCP-Inspection-500.jpg Surviving an FDA GCP Inspection](https://www.centerwatch.com/ext/resources/products/Surviving-an-FDA-GCP-Inspection-500.jpg?height=200&t=1605810958&width=200)
Home » Study Scavenger, CenterWatch partner to widen reach
Study Scavenger, CenterWatch partner to widen reach
August 14, 2013
Study Scavenger, the first bilingual smartphone app to allow patients to search for clinical research studies that meet their health, travel and financial needs, and CenterWatch are partnering to provide sponsors, CROs, research centers and patients a mobile solution to clinical trial needs.
Over the past five years, worldwide mobile app use has grown at a rate of 251%, outpacing the growth of stationary internet use by a factor of 15. Potential research volunteers are a component of this growth. With Study Scavenger’s technology, the potential volunteer can search for research studies by location or perform an advanced search, which allows patients to enter their age, zip code, health conditions, distance willing to travel and requested stipend to locate clinical studies meeting their personal, health and financial needs.
For pharmaceutical companies, the partnership between Study Scavenger and CenterWatch will help optimize the millions of dollars spent on patient recruitment advertising while providing motivated patients the ability to find studies that meet their personal needs.
CenterWatch launched the Clinical Trials Listing Service (CTLS) in 1994 with the sole mission to provide patients and healthcare providers a central location for finding clinical trials. This service is considered the largest online database of industry-funded global clinical trials.
“The service reaches a highly targeted and interested patient community via a wide range of distribution channels—patient eAlerts, social media and collaborative relationships with health associations,” said Joan Chambers, chief operating officer of CenterWatch. “The app, combined with our range of channels, reaches a broader audience ultimately serving the overall clinical trials enterprise.”
Upcoming Events
-
21Oct